Tue 23'rd May 2017
Immune Pharmaceuticals Inc. Stock Analysis
Technical stock analysis for Tue 23'rd May 2017
Sell candidate since 2017-05-12 Loss -13.53%
Immune Pharmaceuticals Inc. lies in the middle of a very wide and strong falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.6% during the next 3 months and, with 90% probability hold a price between USD 1.52 and USD 2.64 at the end of this period.
A buy signal was issued from a pivot bottom point on Monday April 17, 2017, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Immune Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at USD 2.49 and USD 2.77. A break-up above any of these levels will issue buy signals. Immune Pharmaceuticals Inc. gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
Immune Pharmaceuticals Inc. finds support from accumulated volume at USD 2.28. On the upside the stock meets some resistance from accumulated volume at USD 2.79, USD 2.48 and USD 2.82.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 0.14 between high and low, or 6.28%. For the last week, the stock has had a daily average volatility of 7.36%.
Immune Pharmaceuticals Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Immune Pharmaceuticals Inc. holds several negative signals and is within a very wide and strong falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.